Fanconi anemia (FA) is a pleiotropic inherited disease that causes bon
e marrow failure in children. However, the specific involvement of FA
genes in hematopoiesis and their relation to bone marrow (BM) failure
is still unclear. The increased sensitivity of FA cells to DNA cross-l
inking agents such as mitomycin C (MMC) and diepoxybutane (DEB), inclu
ding the induction of chromosomal aberrations and delay in the G2 phas
e of the cell cycle, have suggested a role for the FA genes in DNA rep
air, cell cycle regulation, and apoptosis. We previously reported the
cloning of the FA group C gene (FAG) and the generation of a Fac mouse
model. Surprisingly, the Fac -/- mice did not show any of the hematol
ogic defects found in FA patients, To better understand the relationsh
ip of FA gene functions to BM failure, we have analyzed the in vivo ef
fect of an FA-specific DNA damaging agent in Fac -/- mice, The mice we
re found to be highly sensitive to DNA cross-linking agents; acute exp
osure to MMC produced a marked BM hypoplasia and degeneration of proli
ferative tissues and caused death within a few days of treatment. Howe
ver, sequential, nonlethal doses of MMC caused a progressive decrease
in all peripheral blood parameters of Fac -/- mice. This treatment tar
geted specifically the BM compartment, with no effect on other prolife
rative tissues. The progressive pancytopenia resulted from a reduction
in the number of early and committed hematopoietic progenitors, These
results indicate that the FA genes are involved in the physiologic re
sponse of hematopoietic progenitor cells to DNA damage. (C) 1998 by Th
e American Society of Hematology.